Login ×

name not null
password not null
Verification Code not null Go
Forgot Password?
No account?Create one!
Create An Account
Create An Account ×

Email registration
Mobile phone registration
registrationWay not null
Please enter a valid email address

* Please use a valid email address to create your account.

Password not null
Confirm Password not null

Verification code send to Please click the button Send.

Send
Verification Code not null
Read And accept Privacy Policy
Already have an account? Log in Now.
Change Password
Change Password ×

old Password not null
new Password not null
Confirm Password not null
Confirm
Reset Password
Reset Password ×

Email reset
Mobile phone reset
registrationWay not null
Please enter a valid email address

Verification code send to

Send
Verification Code not null
Password not null
Confirm Password not null
Confirm
Application submitted
OK
Home
About
Future Events
Past Events
Gallery
Support Us
Registration ×
Speakers
Attendees
SMART Symposium on Conquering the Challenges of ALS and Related Neuromuscular Diseases
SMART
Register
Date
October 28-31, 2025
Registration Deadline
October 24, 2025
Venue
Cloud Park International Conference Center, Shenzhen, China
About
Organizers
Confirmed Speakers
Program
Registration
Call for Abstracts
Short Talk Presentation
Poster Session
Accommodation
Contact Us
Download
About
Neuromuscular diseases such as ALS present a global challenge to human health and medicine. Every year, millions suffer from these diseases, and there is still no effective treatment. Emerging efforts from cross-field collaborations led to significant progress toward FDA-approved therapeutics, such as ASO therapies. Our symposium aims to bring together academic, clinical, and industrial experts in ALS and other neuromuscular diseases. Through their brainstorming, we seek to identify ways to conquer the major challenges of these devastating diseases.
Organizers
Xiaojiang LI, Jinan University
Ke ZHANG, Shenzhen Bay Laboratory
Aaron D. GITLERStanford University
Shuying SUNJohns Hopkins University
Confirmed Speakers

Keynote Speakers

(in alphabetic order)

Don W. CLEVELAND, University of California, San Diego

Jeffrey D. ROTHSTEIN, Johns Hopkins University

Junying YUAN, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

 

Invited Speakers

(in alphabetic order)

Ge BAI, Zhejiang University

Gong CHEN, Jinan University

Xiangjun CHEN, Huashan Hospital, Fudan University

Yelin CHEN, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

Sandrine Da CRUZ, VIB-KU Leuven Center for Brain & Disease Research

Dongsheng FAN, Peking University Third Hospital

Fen-Biao GAO, University of Massachusetts Chan Medical School

Yun GE, Shenzhen Bay Laboratory

Siqi HONG, Children's Hospital of Chongqing Medical University

Justin K. ICHIDA, University of Southern California

Ralf JAUCH, The University of Hong Kong

Yichang JIA, Tsinghua University

Clotilde LAGIER-TOURENNE, Massachusetts General Hospital, Harvard Medical School

Andrew Stephen LEE, Shenzhen Bay Laboratory, Peking University Shenzhen Graduate School

Chunghun LIM, Korea Advanced Institute of Science and Technology

Yi LIN, Tsinghua University

Bai LU, Tsinghua University

Magdalini POLYMENIDOU, University of Zurich

Manish RAISINGHANI, Target ALS Foundation

Linhao RUAN, Huazhong University of Science and Technology

Neil A. SHNEIDER, Columbia University

Kun SUN, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Yi SUN, Shenzhen University of Advanced Technology

Ruilin TianSouthern University of Science and Technology

Christine VANDE VELDE, University of Montréal

Keqiang YE, Shenzhen University of Advanced Technology

Program

Day 1 (Tuesday, October 28)

10:30-14:00

Registration

 

 

Short Talks Selected from Abstracts I:

Chairs: Cong LI, Zijuan TONG

14:00-14:20

Peng HAN, Shenzhen Bay Laboratory
Reducing G3BP2 Delays Stress Granule Assembly and Ameliorates Neurodegeneration in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

14:20-14:40

Meizhen ZHENG, Southern University of Science and Technology
PR50 Induces ALS-like Phenotypes via Disruption of RNA Binding Proteins, Chromatin Architecture, and Microglia Homeostasis in Neonatal Mice

14:40-15:00

Kaixin YAN, The Second Affiliated Hospital of Xinjiang Medical University
ALDOA-Induced Glycolysis Exacerbates Motor Neuron Pyroptosis and Accelerates ALS Progression

15:00-15:20

Zirong LIANG, Shenzhen Bay Laboratory

Glycogen Promotes Condensation of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Proteins

15:20-15:30

Break

 

 

Short Talks Selected from Abstracts II:

Chairs: Zirong LIANG, Bojun YANG

15:30-15:50

Marian HRUSKA-PLOCHAN, MaxWell Biosystems AG
High-Density Microelectrode Arrays (HD-MEAs) for Modeling, Phenotyping, and Screening in ALS and FTD

15:50-16:10

Yichen LI, Ractigen Therapeutics
RAG-17, an Intrathecally Administrated SiRNA Therapy for SOD1-ALS

16:10-16:30

Meiling YU, The University of Hong Kong
Ionisable Lipid Nanoparticles (LNPs) for Non-viral Gene Editing Treatment of Amyotrophic Lateral Sclerosis (ALS)

16:30-16:40

Break

 

 

Short Talks Selected from Abstracts III:

Chairs: Bowei LI, Xiaoyu DONG

16:40-17:00

Cong LI, Shenzhen Bay Laboratory
TRPV1 Promotes Stress Granule Assembly and Neurodegeneration in ALS/FTD

17:00-17:20

Tianshuo ZHANG, The Fifth Affiliated Hospital of Sun Yat-sen University
TDP-43 Deficiency-Induced Triglyceride Catabolism Disorder in ALS: Lipid Droplets Accumulation, Insufficient Energy Supply, and Neuronal Degeneration

17:20-17:40

Zijuan TONG, Southern University of Science and Technology
CRISPR Screen Reveals Hijacking of Stress Granule Components in Protein Inclusion Formation in Neurodegenerative Diseases

17:40-18:30

Poster Session

 

 

Day 2 (Wednesday, October 29)

08:00-09:00

On-site Registration

09:00-09:15

Opening and Introductory Remarks

 

 

Keynote Lecture I

Chair: Ke ZHANG, Shenzhen Bay Laboratory

09:15-10:00

Jeffrey D. ROTHSTEIN, Johns Hopkins University

TDP-43 Import: A Whole Genome CRISPRi Screen in Human Neurons Reveals Multiple ALS, FTD, and ALS Genes That Work by Altering TDP-43 Import

10:00-10:30

Group Photo & Break

 

 

Session I. ALS Cell Biology

Chair: Yi LIN, Tsinghua University

10:30-10:55

Linhao RUAN, Huazhong University of Science and Technology

INFINITE: A Screen Platform for Neuronal Nuclear Cytoplasmic Transport Regulators

10:55-11:20

Chunghun LIM, Korea Advanced Institute of Science and Technology

ER–Lysosome Contacts Drive Lipotoxicity in C9ORF72-Associated ALS

11:20-11:45

Sandrine DA CRUZ, VIB-KU Leuven Center for Brain & Disease Research

Uncovering Local Mechanisms of Axon/Synapse Maintenance and Demise in ALS/FTD

11:45-12:10

Magdalini POLYMENIDOU, University of Zurich

Understanding the Life Cycle of TDP-43: Aggregation Triggers & Toxicity Effectors

12:10-12:35

Bai LU, Tsinghua University

New Strategies to Accelerate ALS Drug Development

12:35-14:00

Lunch

 

 

Keynote Lecture II

Chair: Shuying SUN, Johns Hopkins University

14:00-14:45

Don W. CLEVELAND, University of California, San Diego
TBA

 

 

Keynote Lecture III

Chair: Aaron D. GITLER, Stanford University

14:45-15:30

Junying YUAN, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

RIPK1 and Neuroinflammation

15:30-15:40

Break

 

 

Session II. RNA Metabolism and Stress Granules

Chair: Qin PENG, Shenzhen Bay Laboratory

15:40-16:05

Shuying SUN, Johns Hopkins University

RNA Metabolism Dysfunction in C9ORF72-ALS/FTD

16:05-16:30

Clotilde LAGIER-TOURENNE, Massachusetts General Hospital, Harvard Medical School

Disruption of RNA Metabolism in Neurodegenerative Diseases and Emerging Therapeutic Strategies

16:30-16:55

Christine VANDE VELDE, University of Montréal

Stress Granules in ALS/FTD Pathogenesis: Friend or Foe?

16:55-17:20

Ge BAI, Zhejiang University

Stress Granules and Neurodegeneration

17:20-17:45

Ke ZHANG, Shenzhen Bay Laboratory

Novel Ways to Target Stress Granules

17:45-18:30

Poster Session

18:30-20:30

Banquet

 

 

Day 3 (Thursday, October 30)

08:30-09:00

On-site Registration

 

 

Special Lecture

Chair: Ke ZHANG, Shenzhen Bay Laboratory

09:00-09:25

Manish RAISINGHANI, Target ALS Foundation

Target ALS: Pioneering Collaboration and Innovation to Accelerate ALS Research and Drug Discovery

 

 

Session III. Liquid-Liquid Phase Separation

Chair: Linhao RUAN, Huazhong University of Science and Technology

09:25-09:50

Yi LIN, Tsinghua University

Spatiotemporal Control of Biological Processes Through Dynamic Phase Separation

09:50-10:15

Yun GE, Shenzhen Bay Laboratory

Target Protein Manipulation to Reveal Glycosylation Functions in Condensates

10:15-10:25

Break

 

 

Session IV. Animal and iPSC models

Chair: Clotilde LAGIER-TOURENNE, Massachusetts General Hospital, Harvard Medical School

10:25-10:50

Xiaojiang LI, Jinan University

The Pathogenesis of Cytoplasmic TDP-43

10:50-11:15

Fen-Biao GAO, University of Massachusetts Chan Medical School

Understanding Familial and Sporadic ALS/FTD: Novel Insights from Drosophila and iPSC-Derived Patient Motor Neurons

11:15-11:40

Justin K. ICHIDA, University of Southern California

Identifying New Therapeutic Targets for ALS Using Rare Genetic Variants and CRISPR Technology

11:40-12:05

Ralf JAUCH, The University of Hong Kong

Direct Somatic to Neural Stem Cell Conversion to Model and Revert Age-Linked Neurological Disorders

12:05-12:30

Ruilin Tian, Southern University of Science and Technology

Decoding Neurodegeneration through in Vitro and in Vivo CRISPR Screening 

Technologies

12:30-14:00

Lunch

 

 

Session V. ALS Diagnosis and Therapeutics I

Chair: Sandrine DA CRUZ, VIB-KU Leuven Center for Brain & Disease Research

14:00-14:25

Neil A. SHNEIDER, Columbia University

Silencing FUS and Other Rare Genetic Forms of ALS

14:25-14:50

Gong CHEN, Jinan University

In Vivo Neural Regeneration and Its Potential in the Treatment of ALS

14:50-15:15

Dongsheng FAN, Peking University Third Hospital

Preliminary Study on the Treatment of ALS with rTMS Under the Guidance of pBFS

15:15-15:25

Break

 

 

Session VI. ALS Diagnosis and Therapeutics II

Chair: Ge BAI, Zhejiang University

15:25-15:50

Aaron D. GITLER, Stanford University

ALS Therapeutic Targets

15:50-16:15

Yi SUN, Shenzhen University of Advanced Technology
Autologous Rejuvenated Cell Therapy for ALS

16:15-16:40

Yichang JIA, Tsinghua University

From ALS disease models to ALS gene therapy

16:40-17:05

Kun SUN, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Translational Advances in SMA Care: From Novel Diagnostics to Prenatal Gene Therapy in Murine Systems

 

 

Day 4 (Friday, October 31)

08:30-09:00

On-site Registration

 

 

Session VII. Other Neurodegenerative Diseases

Chair: Ralf JAUCH, The University of Hong Kong

09:00-09:25

Keqiang YE, Shenzhen University of Advanced Technology
NMNAT-1 Binds to TDP-43 and Mediates its Copathology in Alzheimer’s Disease

09:25-09:50

Andrew Stephen LEE, Shenzhen Bay Laboratory, Peking University Shenzhen Graduate School

Clinical Translation of Extracellular Vesicle Based Gene Therapy

09:50-10:15

Siqi HONG, Children's Hospital of Chongqing Medical University

Diagnosis and Treatment of NMDs in Children: Current Status and Clinical Challenges

10:15-10:40

Yelin CHEN, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

Using ApoE C-terminal Domain to Treat Alzheimer’s Disease

10:40-11:05

Xiangjun CHEN, Huashan Hospital, Fudan University

Oligogenic ALS Modeling Based on Genotype-Phenotype Correlation from the Huashan TRC Study

11:05-11:15

Closing Remarks and Poster Award Announcement

Registration

Registration Deadline: October 24, 2025

 

Please click the Register link at the top of this web page to proceed with the registration process.

Registration will be closed when the number of applications reaches 250.

 

Registration Fees

*Please upload valid documents for review if you are a student.

 

Notice

1. When making transfers, please include the following note: ALS + [Your Full Name].

2. Please complete the registration and payment before October 24, 2025. Attendees registering on-site will be provided with only the electronic program.

3. The electronic invoice for the registration fee will be sent to the registered email address within 15 working days after the symposium.

 

Refund Policy

1. A 2% administrative fee will be charged for all refund transactions.

2. Refund requests submitted after 18:00 (GMT+8) on October 27, 2025 will not be processed.

Call for Abstracts

Abstract Submission Deadline: September 30, 2025

 

Submission Guidelines:

  • Submit an abstract when registering. Select whether you prefer to present a poster or short talk. Note: Due to limited slots of short talks, we cannot guarantee every abstract selected for short talks. So please be prepared to present a poster even if you selected "Short talk" as your preference.
  • Each presenting author can submit one abstract only.
  • Abstracts will be reviewed by the organizing committee for quality and alignment with the symposium's scope and topics. The organizing committee will also select abstracts for short talks.
  • A confirmation email will be sent to the corresponding authors of each accepted abstract.
Short Talk Presentation

In the afternoon of October 28, we will have a student/postdoc/junior scientist session featuring short talks selected from submitted abstracts. The symposium will cover the registration and accommodation fees for the short talk presenters.

Poster Session

This conference will feature poster presentation sessions, with awards for outstanding posters. We sincerely invite you to submit your topics and participate in the poster presentation (encouraging the display of the latest research advancements or unpublished research topics).

 

How to participate: Upload poster information to the registration website.

 

Poster requirements: If you will present a poster, please print it yourself and bring it to the conference venue. The staff will post it in the designated area.

 

Poster size: Width 80 cm * Height 120 cm

 

Accommodation

We do not provide centralized accommodation for this symposium. Participants can arrange their own accommodation by contacting nearby hotels. (If you encounter any difficulty in booking a hotel, please contact us at symposium@smart.org.cn.)

 

1. EVEN Hotels Shenzhen Guangming Cloud Park, an IHG Hotel

Address: No. 98 Zhenyuan Road, Guangming District, Shenzhen

The hotel is 200 meters (~3-minute walk) from the conference venue.

Contact: Mr. Zhou, Tel: +86-135 0841 8360

 

2. Holiday Inn Express Shenzhen Guangming Cloud Park, an IHG Hotel

Address: No. 98 Zhenyuan Road, Guangming District, Shenzhen

The hotel is 200 meters (~3-minute walk) from the conference venue.

Contact: Mr. Zhou, Tel: +86-135 0841 8360

 

3. SYSU Academic Vila, Shenzhen Campus

Address: No.66 Gongchang Road, Guangming District, Shenzhen, Guangdong, China, Guangming District, Shenzhen

The hotel is 2.5 kilometers (~5-minute drive) from the conference venue.

Contact: Mr. Ran, +86-133 3028 2207

 

4. Guangming CIMC Executive Apartments Hotel

Address: CIMC Executive Apartments Hotel, Qiaoming Road, Fenghuang Street, Guangming District, Shenzhen

The hotel is 7.6 kilometers (~20-minute drive) from the conference venue.

Contact: Mr. Lu, Tel: +86-138 2659 2644

Contact Us

Email: symposium@smart.org.cn

Tel: +86-173 2236 4121

地图显示